- Cannabix Technologies has revealed results from a collection of breath samples from a green lab testing day in Montgomery County, Maryland
- The samples were analyzed at a third-party location and delta9-THC was detected and quantified after smoking and edibles had been consumed
- These samples are the first human breath samples using the company’s proprietary equipment that have been conducted outside of Cannabix’s labs
- Shares of Cannabix Technologies are unchanged at C$0.22
Cannabix Technologies (CSE:BLO) has revealed marijuana detection breath sample collection results from a green lab testing day that took place in Montgomery County, Maryland.
The Vancouver-based company stated in a news release that results were analyzed from breath samples after human subjects smoked and consumed edibles at a third-party location.
Samples were taken in early January during the Maryland green lab hosted by the Montgomery County Police Department and were then shipped to the North Louisiana Criminalistics Laboratory.
This marks the first time the company’s proprietary laboratory-based marijuana detection equipment has been used outside of its labs.
“This is significant milestone for our marijuana breathalyzer system as we have now been able to duplicate our latest quantification processes – outside of our own laboratories – at NCLC,” Rav Mlait, CEO of Cannabix Technologies, said in a statement. “Administrators at NCLC were able to prepare their calibration curve and duplicate Cannabix’s quantification analysis methods and achieve quantified breath samples for delta-9 THC from smoking and edibles. This marks a major step showing the ability to reproduce our breath sample testing methods in multiple locations.”
Data collected came from 11 volunteer subjects – 10 smokers and one subject who consumed THC-infused edibles – and showed comparable results to those from past green lab studies.
Roughly 30 minutes after consumption, the delta9-THC concentration in breath per cartridge increased, with the highest recorded value being around 25 ng/cartridge.
After 60 minutes, THC concentrations decreased but were still above baseline values. Subjects were instructed to re-dose after 80 minutes and analysis indicated elevated levels of delta9-THC in breath at later points.
Samples were analyzed after 48 hours from collection and no adverse effects were reported related to storing or shipping during the analysis process.
Cannabix Technologies’ Breath Collection Unit and MS Breath Sampler are being used in tandem with each other for a new way of drug detection that is easy to use and seamlessly interfaced.
The company is continuing to test and develop the products to quantify delta9 THC in human breath samples.
Cannabix Technologies develops marijuana and alcohol breathalyzer technologies for law enforcement, workplaces and laboratories. Cannabix is working to develop delta-9 THC and alcohol screening devices.
Shares of Cannabix Technologies are unchanged at C$0.22.
Join the discussion: Find out what everybody’s saying about this stock on the Cannabix Technologies Bullboard, and check out the rest of Stockhouse’s stock forums and message boards.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.